TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Jenving Clinical Trial Services AB
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 104 | 112 | 150 |
Financial expenses | 0 | 0 | 0 |
Earnings before taxes | 33 | 28 | 50 |
EBITDA | 31 | 28 | 51 |
Total assets | 162 | 185 | 211 |
Current assets | 136 | 172 | 199 |
Current liabilities | 6 | 9 | 18 |
Equity capital | 147 | 153 | 168 |
- share capital | 4 | 5 | 5 |
Employees (average) | 1 | 1 | 1 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 90.7% | 82.7% | 79.6% |
Turnover per employee | 104 | 112 | 150 |
Profit as a percentage of turnover | 31.7% | 25.0% | 33.3% |
Return on assets (ROA) | 20.4% | 15.1% | 23.7% |
Current ratio | 2266.7% | 1911.1% | 1105.6% |
Return on equity (ROE) | 22.4% | 18.3% | 29.8% |
Change turnover | 1 | -35 | 3 |
Change turnover % | 1% | -24% | 2% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.